Disorder In The Court When Science Takes The Witness Stand

The Frye test, named after a defendant in a 1923 murder case, is the oldest and most popular test used to determine when scientific evidence can be used in court. Using the test, courts admit scientific evidence based on a novel scientific technique only when the technique has gained general acceptance in the relevant scientific field. For example, testimony based on a certain scientific principle is not admissible simply because one expert vouches for the principle. It is not even enough that

Written byJulia King
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

The essential fallacy of the Frye test--also known as the general acceptance test--is that it forces the courts to decide the admissibility of scientific testimony by counting heads. In turn, this can lead to both the admission of untrustworthy evidence and the exclusion of valid evidence. For example, if enough biased experts are willing to vouch for a theory, even an unproven, invalid theory can satisfy the terms of the test. On the other hand, the most brilliant researcher in the world can validate a theory by an impeccably designed experiment, yet the court cannot admit his testimony until the theory passes the popularity contest of "general acceptance" by the scientist's peers. This, in part, explains the continuous battles that take place in U.S. courts over the admissibility of DNA-based evidence. In Britain, where the courts have never followed a general acceptance rule, courts routinely admit DNA-based evidence.

Despite the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies